Genelex, a pioneer in pharmacogenetic testing, analysis and comprehensive medication management software that helps medical professionals understand the interaction between a patient’s genetics and their entire drug regimen, announces its selection as one of the top 100 mid-sized companies to work for in Seattle, for the third consecutive year.

Seattle Business magazine’s annual award is based primarily on anonymous input from employees; winners are then selected from a panel of distinguished local business leaders. Employees are surveyed about what makes them happy with their work – on topics from company leadership, benefits, work environment, and innovation in training programs. The awards were presented Tuesday evening at the magazine’s Award Gala.

Founded in 1987, Genelex has been on a fast-track trajectory of growth since it began focusing on pharmacogenetic testing (also known as drug sensitivity testing) in 2000.  The company’s mission, “science that benefits humanity,” as well as its people-first, entrepreneurial environment make it a highly attractive employer.

“We’ve grown from a small, family-owned company to now employing more than 100 people,” says Howard Coleman, Genelex co-founder and CEO. “It’s gratifying to see our caring company culture and commitment to quality continue while growing at such a high rate. It’s exciting to meet and hire the young professionals motivated by our culture and potential, as we continue to make advances that have a real positive impact on healthcare.”

According to Seattle Business magazine, a record number of companies large and small from all over the state entered this competition. “To make the list this year especially, when so many did not, is a powerful statement about how winning companies treat their people,” notes Michael Romoser, associate publisher of Seattle Business.

To learn more about Genelex and current employment opportunities, please visit www.Genelex.com.

#   #   #

About Genelex

Genelex is a pioneer in comprehensive medication management, pharmacogenetic testing and analysis. Its patented YouScript^® Personalized Prescribing System is the only medication management system to assess the cumulative effect of a patient’s genetics and entire drug regimen to help prevent unwanted side effects and treatment failures.  YouScript was a finalist in the Allscripts Open App Challenge, and is used by healthcare providers, clinical researchers and managed and accountable care organizations. Founded in 1987, Genelex is based in Seattle and was one of the first labs to provide pharmacogenetic testing and interpretation.  For more information, contact the company at 800.TEST.DNA or visit www.genelex.com or www.youscript.com.